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J O U R N A L O F T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y , V O L . 6 6 , N O . 1 5 , S U P P L B , 2 0 1 5 B75METHODS Hemodynamic data were available for 140/302 patients in
the SHOCK trial and 260/1189 in the SHOCK registry. We explored the
number of patients meeting criteria for RVD as deﬁned by:
CVP>10mmHg, CVP/PCWP>0.63, PAPi<2.0 and RVSWI<450
mmHg$mL/m2. Next, we explored the number of patients who met
the RR-RVF criteria in the trial and registry. Finally, we examined
whether RVD or the RR-RVF criteria were associated with 30 day
mortality.
RESULTS RVD was observed in 37% and 36% of patients in the SHOCK
trial and registry respectively. RR-RVF criteria were observed in 45%
and 38% of SHOCK trial and registry patients respectively. Among trial
patients, RR-RVF criteria were not associated with increased 30-day
mortality. Among registry patients, 30 day mortality was higher
among patients who met RR-RVF criteria compared to those who did
not (58% vs 44%, p¼0.03). RR-RVF criteria were associated with a
hazard ratio of 1.46[1.03-2.07] (p¼0.04) for 30-day mortality among
registry subjects.CONCLUSIONS RVD was commonly observed among patients in the
SHOCK trial and registry. The RR-RVF criteria were associated with
increased 30-day mortality in both the SHOCK trial and registry. These
ﬁndings suggest that univentricular shock is uncommon in AMI-CS.
Early recognition and aggressive management of RVD may improve
clinical outcomes in AMI-CS. Future studies are required to further
explore the potential clinical utility of the RR-RVF criteria.
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Assessment Of Aortic Valve Location On Supine Chest X-ray. Applicability
Of The Aortic Valve Location Ratio For Assessment Of Intra-cardiac Assist
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BACKGROUND The use of intra-cardiac assist devices is expanding
and correct position of these devices is required for optimal func-
tioning. The aortic valve is an important landmark for positioning
intra-cardiac assist devices. It would be of great value if the device
position could be determined accurately by plain supine chest X-ray.
We aimed to introduce a ratio for determination of the aortic valve
location on plain supine chest X-ray images in the intensive care unit.
METHODS Supine anterior-posterior chest X-ray of patients with an
aortic valve prosthesis (n¼475) were analyzed to determine thelocation of the aortic valve using the Aortic Valve Location (AVL) ratio.
The AVL ratio was validated using computer tomography of patients
with angina pectoris without known valvular disease (n¼95). The
position of a Impella device was determined on chest X-ray and
compared to echocardiographic images (n¼34).
RESULTS The AVL ratio determines the location of the aortic valve
caudal to the carina, at a distance of 0.270.05 times the thoracic
width. When the AVL ratio is used for assessment of the position of a
cardiac assist device it shows a good correlation with
echocardiography.
CONCLUSIONS The Aortic Valve Location Ratio enables accurate and
reproducible localization of the aortic valve on supine chest X-ray.
This tool is easily applicable and can be used for assessment of cardiac
device position in patients on the Intensive care unit.CATEGORIES CORONARY: Hemodynamic Support and Cardiogenic
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BACKGROUND Refractory cardiogenic shock (RCS) in acute myocar-
dial infarction (AMI) is associated with high mortality rates. Impella
and intra-aortic balloon pump (IABP) provide only limited left ven-
tricular (LV) support. Veno-arterial Extracorporeal membrane
oxygenation (VA-ECMO) and peripheral ventricular assist device,
TandemHeart (p-VAD), have been claimed to provide superior LV
support. However, limited data exists on the outcomes of VA-ECMO
and p-VADs in this speciﬁc population. This study aimed to compare
VA-ECMO and p-VAD in patients presented with RCS complicated by
AMI.
METHODS Using prospective registries, we identiﬁed patients un-
dergoing VA-ECMO or p-VAD placements for an indication of AMI with
RCS. Clinical, procedural and clinical outcomes data were recorded for
both groups. A comparative analysis of use of these two devices in
AMI was performed.
RESULTS In the study there were 35 patients who presented with
RCS. 16 patients were assigned to VA-ECMO and 19 to p-VAD. Baseline
clinical characteristics were similar between the groups except for
higher incidence of diabetes (58% vs. 9%, p¼0.03) in the p-VAD group.
Door to device time was also longer in the p-VAD group. Overall the
survival rate in hospital (58% vs.56%, p¼0.45) and at 30 days (58% vs.
56%, p¼0.3) were similar in both groups. There was no signiﬁcant
difference in the incidence of complications including limb ischemia
requiring surgery, signiﬁcant hemolysis, need for renal replacement
therapy, stroke or recurrent myocardial infarction between the two
